Apotheek Maxime Van Eetvelde
ActiveApotheek Maxime Van Eetvelde has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €108k and a net result of €1k. Equity is growing by ~20% per year across the filed fiscal years. Its solvency ranks better than 41% of 18024 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability5▼-95
Solvency41▼-10
Growth78=
Stability100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days only on tighter terms
Liquidity tight (current ratio 1.29 against 1.35 in 2024), and 76.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
23.9%
Return on assets
0.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
11 d early
2024
12 d late
2023
41 d early
2022
10 d late
2021
34 d early
2020
37 d early
2019
38 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€108k▲ 1.0%
2024 · €107k
2018: €33k
2019: €28k
2020: €41k
2021: €57k
2022: €63k
2023: €68k
2024: €107k
2018 → 2025
Total assets
€453k▲ 17.0%
2024 · €387k
2018: €352k
2019: €291k
2020: €267k
2021: €353k
2022: €295k
2023: €370k
2024: €387k
2018 → 2025
Net result
€1k▼ 97.1%
2024 · €39k
2018: €-8k
2019: €-5k
2020: €13k
2021: €22k
2022: €6k
2023: €5k
2024: €39k
2018 → 2025
Working capital
€99k▲ 0.8%
2024 · €98k
2018: €63k
2019: €64k
2020: €59k
2021: €59k
2022: €53k
2023: €43k
2024: €98k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€57k-€63k▲ 10.4%€68k▲ 7.5%€107k▲ 57.4%€108k▲ 1.0%
Operating result€33k-€14k▼ 58.3%€14k▼ 2.4%€69k▲ 408%€13k▼ 81.4%
Net result€22k-€6k▼ 72.8%€5k▼ 20.1%€39k▲ 721%€1k▼ 97.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 81% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €453k
Fixed assets
€10k▲ 9.4%
Current assets
€444k▲ 17.2%
Equity and liabilities €453k
Equity
€108k▲ 1.0%
Debt
€345k▲ 23.2%
The debt ratio rises from 72.3% to 76.1%: debt grows faster than equity.
Key figures and ratios
EBITDA
€15k▼
2024 · €95k
Cash flow
€3k▼
2024 · €65k
Solvency
23.9%▼
2024 · 27.7%
Current ratio
1.29▼
2024 · 1.35
Quick ratio
0.98▼
2024 · 1.02
Debt / equity
3.19▲
2024 · 2.61
ROE
1.0%▼
2024 · 36.4%
ROA
0.2%▼
2024 · 10.1%
Interest coverage
1.06▼
2024 · 5.51
Debt
€345k▲
2024 · €280k
Debt ≤ 1 year
€345k▲
2024 · €280k
Income taxes
€1k▼
2024 · €16k
Staff costs
€19k▼
2024 · €35k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€387k€453k▲
Fixed assets21/28€9k€10k▲
Intangible fixed assets21€0-
Tangible fixed assets22/27€9k€10k▲
Plant, machinery and equipment23€7k€8k▲
Furniture and vehicles24€2k€1k▼
Financial fixed assets28€75€75=
Current assets29/58€378k€444k▲
Stocks and contracts in progress3€92k€106k▲
Stocks30/36€92k€106k▲
Amounts receivable within one year40/41€246k€298k▲
Trade receivables40€47k€116k▲
Other amounts receivable41€199k€181k▼
Cash at bank and in hand54/58€39k€36k▼
Deferred charges and accrued income490/1€2k€4k▲
Equity and liabilities
Total equity and liabilities10/49€387k€453k▲
Equity10/15€107k€108k▲
Contributions10/11€30k€30k=
Reserves13€27k€27k=
Distributable reserves133€27k€27k=
Profit (loss) carried forward14€50k€51k▲
Amounts payable17/49€280k€345k▲
Amounts payable after more than one year17€0-
Financial debts170/4€0-
Amounts payable within one year42/48€280k€345k▲
Current portion of amounts payable after more than one year42€10k€4k▼
Financial debts43€100k€75k▼
Credit institutions430/8-€75k
Other loans439€100k€0▼
Trade debts44€83k€148k▲
Suppliers440/4€83k€148k▲
Taxes, remuneration and social security45€37k€4k▼
Taxes450/3€20k€1k▼
Remuneration and social security454/9€17k€3k▼
Other amounts payable47/48€51k€114k▲
Accrued charges and deferred income492/3-€561
Income statement
Code20242025
Remuneration, social security and pensions62€35k€19k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€26k€2k▼
Other operating charges640/8€2k€2k▼
Gross operating margin9900€132k€36k▼
Operating profit (loss)9901€69k€13k▼
Financial income75/76B€3k€3k▲
Recurring financial income75€3k€3k▲
Financial charges65/66B€17k€14k▼
Recurring financial charges65€17k€14k▼
Profit (loss) for the period before taxes9903€55k€2k▼
Income taxes67/77€16k€1k▼
Profit (loss) for the period9904€39k€1k▼
Profit (loss) for the period to be appropriated9905€39k€1k▼
Appropriation of the result
Profit (loss) to be appropriated9906€50k€51k▲
Profit (loss) brought forward from the previous period14P€11k€50k▲
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
12-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 12 days late
2024
31-12
Financial
Highest result since 2018net €39k ▲721%
Operating result €69k, net result €39k, both a record.
31-12
Financial
Equity above €100kEq €107k ▲57.4%
5 profitable years in a row build equity to €107k.
20-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
10-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 10 days late
2022
27-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
24-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Back to profitnet €13k
Net result €13k after 2 loss-making years.
23-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
28-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
25-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
23-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beveren-Kruibeke-Zwijndrecht · 1 establishment unit since 2014
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Geeraard de Cremerstraat 129150 Beveren-Kruibeke-ZwijndrechtGround area
623 m²
Building footprint
288 m²
Volume, LiDAR
1,955 m³
Parcel 46018A0090/00F000, Flanders · tallest building 13.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Apotheek Maxime Van Eetvelde
since 20142.237.794.948
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46018A0090/00F000 | Flanders | 623 m² | 1 · 288 m² | 13.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 · 2 entries · 2,075 EUR awarded · 2,075 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 2 | 2,075 EUR | 2,075 EUR |
Schemes
Hinderpremie bij openbare werken
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
APOTHEEK VANSCHOENWINKEL
BE 0873.591.502
Leuven · Eq €108k
PHARMACIE DE L'ABBAYE
BE 0862.761.352
Stavelot · Eq €108k
MEGA PHARMA
BE 0760.552.551
Merchtem · Eq €108k
HEMIFAR
BE 0421.142.524
Hemiksem · Eq €108k
CLEMENT PHARMA SERVICES
BE 0886.394.314
Meise · Eq €109k
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 3,434 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded08-12-2014
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47783Retail trade
47784Retail trade
Sources
Crossroads Bank for EnterprisesNational Bank · 11 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:vaneetveldemaxime@hotmail.com
Phone:0499/327458